STAAR Surgical announces preliminary Q3 net sales $94.7M (+6.9%); includes $25.9M China shipment

STAAR SURGICAL CO

2025-Q3 EPS reported -$1.26 vs consensus $0.16 ▼ miss (-865.0%)

Preliminary net sales $94.7M, up 6.9% YoY from $88.6M; outside China grew 7.7%.
$25.9M from December 2024 China ICL shipment recognized in Q3 upon payment receipt.
China distributors reduced inventory by ~$80-85M over nine months; new Q3 orders fell.
Distributor inventory at ~6 months as of Sep 26, aligned to contractual levels.
Special meeting Oct 23 to vote on Alcon merger proposal; early release for stockholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.